🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06713031
Starting soon Not applicable

Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

NCT06713031 · tracked via the Priya Life Science China tracker
Sponsor
Chinese PLA General Hospital
Phase
Not applicable
Started
2024-12-10
Last updated
2024-12-04

Condition(s) studied

Fracture of Neck of Femur

Investigational drug(s) / intervention(s)

cannulated compression screws + iliac bone graftDCS + medial support plate + iliac bone graft

cannulated compression screws + iliac bone graft: Using "cannulated compression screws + iliac bone graft" technique to treat old femoral neck fractures

DCS + medial support plate + iliac bone graft: Using "DCS + medial support plate + iliac bone graft" technique to treat old femoral neck fractures

Study summary

A prospective, multi-center, randomized controlled study was conducted to validate the safety and effectiveness of employing the medial augmentation technique (incorporating the dynamic condylar screw and medial support plate) supplemented with bone grafting for the treatment of old femoral neck fractures.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age \>= 18 years, gender not specified; 2. Patients with femoral neck fractures who have not undergone surgery for more than 3 weeks, or patients with persistent non-union following internal fixation of femoral neck fractures; 3. Have indications for internal fixation surgery for femoral neck fractures and are able to tolerate the surgery; 4. Participants or their legal representatives are informed about the nature of this study and agree to participate. Exclusion Criteria: 1. Participants who have not reached the primary endpoint of other drug, biological agent, or medical device clinical trials prior to enrollment; 2. Known history of hypersensitivity to one or more implanted materials by the patient; 3. Judged by the investigator as physically frail or unable to tolerate surgery due to other systemic diseases; 4. Active infectious foci in the hip joint or other parts of the body, as judged by the investigator; 5. Diagnosed with metabolic bone disease, radiation-induced bone disease, etc.; 6. Severe hip contracture deformity or severe muscle weakness that has been immobilized in functional position for a long time and painless; 7. Suffering from inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.; 8. Patients who lack the mental capacity or understanding to meet the requirements of participating in the study, or are difficult to cooperate with; 9. Other situations where the investigator deems the participant unsuitable for inclusion.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chinese PLA General Hosptial Beijing China

More Chinese PLA General Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06713031 on ClinicalTrials.gov ↗ ← All trials in China